rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Charles Theuer

Director

Company insider

Files Form 4 as: Director, 4D Molecular Therapeutics; Director, Oncternal Therapeutics; President and CEO, Tracon Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
90
Buys
45
Sells
3
Bought
$749K
Sold
$217K
Companies
3
Companies where not an officer
2
First trade
26 Mar 2015
Last trade
17 Jun 2026
Last filed
18 Jun 2026

Companies traded

Where they are an officer
Tracon PharmaceuticalsDirector, Officer · last 12 Mar 202445 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
FDMT 4D Molecular TherapeuticsDirector · Biotechnology · last 17 Jun 20260 buys · 0 sells
Oncternal TherapeuticsDirector · last 20 Jun 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 18 Jun 2026FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
17 Jun 2026filed 18 Jun 2026FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
12 Dec 2025filed 16 Dec 2025FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—9,333 at $0.00filing
12 Dec 2025filed 16 Dec 2025FDMT 4D Molecular TherapeuticsBiotechnologySEC FORM 4 Code M$11K9,333 at $1.14filing
17 Jun 2025filed 20 Jun 2025FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,500 at $0.00filing
20 Jun 2024filed 24 Jun 2024Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code A—2,200 at $0.00filing
21 May 2024filed 23 May 2024FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,500 at $0.00filing
12 Mar 2024filed 13 Mar 2024Tracon Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—518,300 at $0.00filing
20 Oct 2023filed 13 Mar 2024Tracon PharmaceuticalsSEC FORM 4 Code A$4553,500 at $0.13filing
28 Jun 2023filed 30 Jun 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code A—25,000 at $0.00filing
23 May 2023filed 25 May 2023FDMT 4D Molecular Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—22,500 at $0.00filing
27 Apr 2023filed 28 Apr 2023Tracon PharmaceuticalsSEC FORM 4 Bought$35K47,000 at $0.75filing
26 Apr 2023filed 28 Apr 2023Tracon PharmaceuticalsSEC FORM 4 Bought$2,6393,999 at $0.66filing
20 Apr 2023filed 13 Mar 2024Tracon PharmaceuticalsSEC FORM 4 Code A$4903,500 at $0.14filing
1 Mar 2023filed 2 Mar 2023Tracon PharmaceuticalsSEC FORM 4 Bought$7,2964,800 at $1.52filing
28 Feb 2023filed 2 Mar 2023Tracon PharmaceuticalsSEC FORM 4 Bought$304200 at $1.52filing
1 Feb 2023filed 3 Feb 2023Tracon Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—332,000 at $0.00filing
18 Jan 2023filed 19 Jan 2023Tracon PharmaceuticalsSEC FORM 4 Bought$11K6,800 at $1.62filing
14 Dec 2022filed 15 Dec 2022Tracon PharmaceuticalsSEC FORM 4 Bought$30K23,000 at $1.29filing
18 Nov 2022filed 22 Nov 2022Tracon PharmaceuticalsSEC FORM 4 Bought$20K13,900 at $1.41filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed48

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.